R. Walter

发表

High-resolution macromolecular structure determination using CCD detectors and synchrotron radiation.

M. Wall, E. Eikenberry, M. Tate, 1995, Structure.

Identification of a Glycogen Synthase Kinase‐3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice

C. McClung, A. Mesecar, A. Kozikowski, 2011, ChemMedChem.

The development of new bicyclic pyrazole-based cytokine synthesis inhibitors.

R. Walter, R. Bookland, A. Gołębiowski, 2004, Bioorganic & medicinal chemistry letters.

The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.

R. Walter, R. Bookland, A. Gołębiowski, 2005, Bioorganic & medicinal chemistry letters.

The development of new triazole based inhibitors of tumor necrosis factor-α (TNF-α) production

R. Walter, R. Bookland, A. Gołębiowski, 2003 .

Design and synthesis of substituted pyridine derivatives as HIF-1alpha prolyl hydroxylase inhibitors.

R. Walter, Shengde Wu, M. Pokross, 2006, Bioorganic & medicinal chemistry letters.

Design and synthesis of a series of novel pyrazolopyridines as HIF-1alpha prolyl hydroxylase inhibitors.

Carol Winter, R. Walter, Shengde Wu, 2006, Bioorganic & medicinal chemistry letters.

A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1alpha prolyl hydroxylase inhibitors.

R. Walter, Shengde Wu, M. Pokross, 2006, Bioorganic & medicinal chemistry letters.

Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1alpha prolyl hydroxylase inhibitors.

Carol Winter, R. Walter, Shengde Wu, 2006, Bioorganic & medicinal chemistry letters.

Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex.

F. Winkler, A. D'arcy, C. Chene, 2000, Structure.

Isolation and expression of a Malassezia globosa lipase gene, LIP1.

T. Keough, M. P. Lacey, R. Walter, 2007, The Journal of investigative dermatology.

X-Ray Crystallographic and Kinetic Analysis of Human Purine Nucleoside Phosphorylase Complexes with 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carobxamide and 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamidine

J. Symerský, S. Ealick, R. Walter, 1994 .

Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-alpha production.

M. Natchus, R. Walter, R. Bookland, 2004, Journal of medicinal chemistry.

Development of N-2,4-pyrimidine-N-phenyl-N'-alkyl ureas as orally active inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 2.

Biswanath De, R. Walter, R. Bookland, 2006, Bioorganic & medicinal chemistry letters.

Rational protein engineering in action: the first crystal structure of a phenylalanine tRNA synthetase from Staphylococcus haemolyticus.

B. Beattie, E. Fauman, B. Finzel, 2008, Journal of structural biology.

Purine nucleoside phosphorylase. 2. Catalytic mechanism.

W. Guida, M. Erion, S. Ealick, 1997, Biochemistry.

The development of monocyclic pyrazolone based cytokine synthesis inhibitors.

Jennifer A Townes, Biswanath De, R. Walter, 2005, Bioorganic & medicinal chemistry letters.

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants☆

Udo Oppermann, Frank Von Delft, Kathryn L. Kavanagh, 2015, Bone.

The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).

R. Walter, A. Evdokimov, A. Gołębiowski, 2006, Bioorganic & medicinal chemistry letters.

Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics.

A. Wlodawer, S. Smith‐Gill, Mi Li, 2012, Biochemistry.

Multiple wavelength anomalous diffraction (MAD) crystal structure of rusticyanin: a highly oxidizing cupredoxin with extreme acid stability.

A. Friedman, M. Shoham, S. Ealick, 1996, Journal of molecular biology.

Structure of human desArg-C5a.

W. Boyar, W. Cook, S. Ealick, 2010, Acta crystallographica. Section D, Biological crystallography.

Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.

Jeff T Roesgen, C. Hopkins, R. Walter, 2006, Bioorganic & medicinal chemistry letters.

Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors

A. Curnow, L. Grinius, R. Walter, 2006, Proteins.

The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-alpha production.

R. Walter, R. Bookland, A. Gołębiowski, 2006, Bioorganic & medicinal chemistry letters.

Crystal structure of protein isoaspartyl methyltransferase: a catalyst for protein repair.

R L Walter, A. Friedman, M. Skinner, 2000, Structure.

SR instrumentation for optimized anomalous scattering and high resolution structure studies of proteins and nucleic acids (invited)

Nigel M. Allinson, John R. Helliwell, Sean McSweeney, 1995 .

The crystal structures of the psychrophilic subtilisin S41 and the mesophilic subtilisin Sph reveal the same calcium‐loaded state

O. Almog, G. Shoham, Ana González, 2009, Proteins.

Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.

K. Peters, R. Walter, M. Pokross, 2006, Acta crystallographica. Section D, Biological crystallography.

Synchrotron beamlines for macromolecular crystallography

Steven E. Ealick, S. Ealick, R. Walter, 1993 .

Crystal structure of recombinant human interleukin-4.

S E Ealick, R L Walter, C. Bugg, 1994, The Journal of biological chemistry.

Fluorine Labeling of the HyHEL 10 Antibody A ff ects Antigen Binding and Dynamics

A. Wlodawer, S. Smith‐Gill, Mi Li, 2012 .

Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution.

Z Otwinowski, J. Bolin, Z. Otwinowski, 1996, Biochemistry.

The development of novel inhibitors of tumor necrosis factor-α (TNF-α) production based on substituted [5,5]-bicyclic pyrazolones

R. Walter, A. Gołębiowski, M. J. Janusz, 2004 .